Interestingly, it was later observed that the GPR109a expression in microglial cells was increased in in vivo experimental models of neuroinflammation, which is a common feature of Parkinson’s disease and other neurodegenerative pathologies (Fu et al., 2015b). This evidence concerns the gene HCAR2 and Parkinson disease.